A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT07821944

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07821944
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
India (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07821944. Randomized; triple masking; primary purpose treatment. Start 2026-10-15 (actual); primary completion 2027-11-26 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
Condition
Hyperlipidemia
Condition
Hypercholesterolemia
Intervention (Drug)
Enlicitide Decanoate
Intervention (Other)
Placebo
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct07821944
Content hash
1028bb05b76f2ebf9833e47e04ffeb5f795d6e8e508720a1382adf20f1d7e22b